SCHEMBL4074401

SCHEMBL4074401

C[S+](C)C=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3602112 0.83
SCHEMBL10403961 0.59
SCHEMBL17367302 0.56
Iodide SCHEMBL8945711 0.53
Bromide SCHEMBL6041005 0.53
SCHEMBL10798563 0.50
SCHEMBL9705650 0.50
SCHEMBL1128868 0.50
SCHEMBL19565 0.50
SCHEMBL76286 0.47

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421100-B1 CHEMICAL SYNTHESIS OF SOLAMARGINE GLYCOMED SCIENCES LTD (KY) 2008-07-09 EP claimed
WO-2012160337-A1 SULFATED OLIGOSACCHARIDES FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES KINGS COLLEGE LONDON (GB) 2012-11-29 WO disclosed
EP-2084153-A1 THIONUCLEOSIDES AND PHARMACEUTICAL APPLICATIONS UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2009-08-05 EP disclosed
WO-2008059130-A1 THIONUCLEOSIDES AND PHARMACEUTICAL APPLICATIONS UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2008-05-22 WO disclosed